net losses from gambling
Action on Exforge: Novartis has received tentative FDA approval for its combination hypertension treatment Exforge (amlodipine/valsartan), but cannot launch or promote the product until September 2007, following patent and exclusivity expiration of Pfizer's Norvasc (amlodipine). Approval of the... Related Results "N"e old drug won't do Pfizer profit, sales drop after US license losses PFIZER.(Brief Article)(Statistical Data Included) Worldwide Sales of Prescription Generic Drugs to Exceed $48 Billion by 2010. book casino only player sports casino gambling crime impact credit cards that accept gambling how to get help for gambling
